AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Balance Sheet
NASDAQ:AMPH - Nasdaq - US03209R1032 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 182.78M | 151.61M | 144.30M | 156.10M | 126.40M | |||
| Marketable Securities | 54.10M | 70.04M | 112.51M | 19.70M | 10.30M | |||
| Receivables | 145.39M | 138.04M | 115.47M | 89.00M | 78.90M | |||
| Inventories | 185.48M | 153.74M | 105.83M | 103.60M | 92.80M | |||
| Other Current Assets | 20.21M | 20.65M | 11.49M | 10.00M | 9.70M | |||
| Total Current Assets | 587.96M | 534.07M | 489.60M | 378.30M | 318.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 353.76M | 344.63M | 315.64M | 264.60M | 271.50M | |||
| Investments And Advances | 5.91M | 11.00M | 15.21M | 2.40M | 4.00M | |||
| Goodwill | 3.16M | 3.05M | 3.22M | 3.10M | 3.30M | |||
| Intangibles | 581.37M | 587.61M | 610.08M | 34.20M | 35.60M | |||
| Other Non-Current Assets | 94.11M | 97.12M | 79.16M | 59.40M | 39.10M | |||
| Total Non-Current Assets | 1.04B | 1.04B | 1.02B | 363.70M | 353.40M | |||
| TOTAL ASSETS | 1.63B | 1.58B | 1.51B | 742.00M | 671.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 224.00K | 234.00K | 436.00K | 3.00M | 2.20M | |||
| Accrued Expenses | 130.87M | 133.35M | 197.92M | 66.70M | 70.30M | |||
| Accounts Payable | 52.81M | 30.51M | 25.44M | 20.50M | 22.20M | |||
| Other Current Liabilities | 15.14M | 9.66M | 1.61M | 4.60M | 9.10M | |||
| Total Current Liabilities | 199.05M | 173.76M | 225.41M | 94.90M | 103.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 603.86M | 601.63M | 589.58M | 72.80M | 74.80M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 100.00K | 500.00K | |||
| Other Non-Current Liabilities | 72.08M | 69.78M | 58.51M | 45.50M | 46.90M | |||
| Total Non-Current Liabilities | 675.94M | 671.41M | 648.08M | 118.40M | 122.20M | |||
| TOTAL LIABILITIES | 874.99M | 845.17M | 873.49M | 213.30M | 226.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 594.07M | 568.79M | 409.27M | 271.70M | 180.30M | |||
| Additional Paid In Capital | 509.11M | 505.40M | 486.06M | 455.10M | 422.40M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 6.00K | 6.00K | 6.00K | 0.00 | 0.00 | |||
| Treasury Stock | -343.93M | -332.71M | -247.43M | -189.50M | -150.50M | |||
| Other Shareholders' Equity | -7.97M | -9.18M | -8.48M | -8.60M | -6.80M | |||
| Shares Outstanding | 47.67M | 47.62M | 48.07M | 48.10M | 47.70M | |||
| Tangible Book Value per Share | 3.50 | 2.97 | 0.54 | 10.22 | 8.52 | |||
| Total Shareholders' Equity | 751.28M | 732.30M | 639.42M | 528.70M | 445.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.63B | 1.58B | 1.51B | 742.00M | 671.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.80 | 0.82 | 0.92 | 0.14 | 0.17 | |||
| Current Ratio | 2.95 | 3.07 | 2.17 | 3.99 | 3.06 | |||
| Return On Assets (ROA) | 8.71% | 10.11% | 9.09% | 12.32% | 9.25% | |||
| Return On Equity (ROE) | 18.85% | 21.78% | 21.51% | 17.29% | 13.94% | |||
| Return On Invested Capital (ROIC) | 11.31% | 12.13% | 12.86% | 13.77% | 10.21% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 13.56% | 14.41% | 16.06% | 18.91% | 13.44% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 26.64% | 28.79% | 39.66% | 20.53% | 14.78% | |||
All data in USD , ROIC based on taxRate of 0.17